Literature DB >> 6769730

Immunohistochemical localization of aldose reductase. II. Rat eye and kidney.

M A Ludvigson, R L Sorenson.   

Abstract

Aldose reductase (AR) was purified from rat seminal vesicles. Specific antibodies to this enzyme were prepared in rabbits and were used in the unlabeled antibody-enzyme (PAP) technique to localize AR in a number of tissues known to be sites of diabetic lesions. AR was localized in the following structures in the eye: lens epithelial lining and cortical lenticular fibers; corneal endothelium; the inner, nonpigmented layer of ciliary body epithelium and its extension as the posterior surface of the iris; and neuroglial (Müller) cells in the retina. Retinal capillary endothelium did not contain immunoreactive AR. In the kidney, staining was intense in the inner medulla. Specific structures included thin limbs of the loop of Henle, collecting tubules deep in the inner medulla, and transitional epithelial cells lining the pelvic space: structures in the cortex including glomerular podocytes and distal convoluted tubules. Collecting tubules in the outer medulla and cortex, as well as proximal convoluted tubules and glomerular capillary endothelium did not contain immunoreactive AR.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769730     DOI: 10.2337/diab.29.6.450

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

1.  Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.

Authors:  Viktor R Drel; Pal Pacher; Martin J Stevens; Irina G Obrosova
Journal:  Free Radic Biol Med       Date:  2006-01-31       Impact factor: 7.376

Review 2.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 3.  Fructose and uric acid in diabetic nephropathy.

Authors:  Petter Bjornstad; Miguel A Lanaspa; Takuji Ishimoto; Tomoki Kosugi; Shinji Kume; Diana Jalal; David M Maahs; Janet K Snell-Bergeon; Richard J Johnson; Takahiko Nakagawa
Journal:  Diabetologia       Date:  2015-06-07       Impact factor: 10.122

Review 4.  Endothelial cell function in diabetic microangiopathy.

Authors:  M Porta; M La Selva; P Molinatti; G M Molinatti
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

5.  Some physical and immunological properties of ox kidney biliverdin reductase.

Authors:  E M Rigney; O Phillips; T J Mantle
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

6.  Topical aldose reductase inhibitor.

Authors:  D Coster
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

7.  Quantitative properties of Müller cells in rabbit retina as revealed by histochemical demonstration of NADH-diaphorase activity.

Authors:  A Reichenbach; F Wohlrab
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

Review 8.  Fructose Production and Metabolism in the Kidney.

Authors:  Takahiko Nakagawa; Richard J Johnson; Ana Andres-Hernando; Carlos Roncal-Jimenez; Laura G Sanchez-Lozada; Dean R Tolan; Miguel A Lanaspa
Journal:  J Am Soc Nephrol       Date:  2020-04-06       Impact factor: 10.121

9.  Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA.

Authors:  T Yamaoka; C Nishimura; K Yamashita; M Itakura; T Yamada; J Fujimoto; Y Kokai
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

10.  The polyol pathway. A historical review.

Authors:  R S Clements
Journal:  Drugs       Date:  1986       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.